Cervical tissue changes in women with miscarriage: A morphological and biochemical investigation

Acta Obstetricia et Gynecologica Scandinavica

Volumn 89, Issue 1, 2010, Pages 54-64

  Radulovic, Nina Vukas ^a   Ekerhovd, Erling ^a   Abrahamsson, Gun ^a   Norström, Anders ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cervical ripening; Electron microscopy; IL 8; Miscarriage; MMP

Indexed keywords

COLLAGEN; COLLAGENASE; GELATINASE B; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; NEUTROPHIL COLLAGENASE;

ADULT; ARTICLE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOHISTOCHEMISTRY; MAST CELL; METABOLISM; PATHOLOGY; PREGNANCY; SPONTANEOUS ABORTION; ULTRASTRUCTURE; UTERINE CERVIX;

ABORTION, SPONTANEOUS; ADULT; CERVIX UTERI; COLLAGEN; COLLAGENASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; MAST CELLS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 74049161123     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016340903390737     Document Type: Article

References (26)

1. Blohm F, Friden B, Milsom I. A prospective longitudinal population-based study of clinical miscarriage in an urban Swedish population. BJOG. 2008; 115:176-83.
2. Nielsen S, Hahlin M, Platz-Christensen J. Randomised trial comparing expectant with medical management for first trimester miscarriages. Br J Obstet Gynaecol. 1999; 106:804-7.
3. Jurkovic D, Ross JA, Nicolaides KH Expectant management of missed miscarriage. Br J Obstet Gynaecol. 1998; 105:670-1.
4. Nielsen S, Hahlin M, Platz-Christensen JJ. Unsuccessful treatment of missed abortion with a combination of an anti-progesterone and a prostaglandin E1 analogue. Br J Obstet Gynaecol. 1997; 104:1094-6.
5. Liggins GC. Cervical ripening as an inflammatory reaction. In: Ellwood DA & Anderson ABM, editors. The cervix in pregnancy and labour. Clinical and biochemical investigation. Edinburgh: Churchill Livingstone, 1981. pp. 1-9.
6. Osmers RG, Blaser J, Kuhn W., Tschesche H. Interleukin-8 synthesis and the onset of labor. Obstet Gynecol. 1995; 86:223-9.
7. Osmers R, Rath W, Adelmann-Grill BC, Fittkow C., Kuloczik M, Szeverenyi M, et al Origin of cervical collagenase during parturition. Am J Obstet Gynecol. 1992; 166:1455-60.
8. von Hertzen H., Honkanen H, Piaggio G., Bartfai G, Erdenetungalag R, Gemzell-Danielsson K, et al WHO multinational study of three misoprostol regimens after mifep-ristone for early medical abortion. I: Efficacy. BJOG. 2003; 110:808-18.
9. Ngoc NT, Blum J, Westheimer E., Quan TT, Winikoff B. Medical treatment of missed abortion using misoprostol. Int J Gynaecol Obstet. 2004; 87:138-42.
10. Hill LM, Guzick D, Fries J., Hixson J. Fetal loss rate after ultrasonically documented cardiac activity between 6 and 14 weeks, menstrual age. J Clin Ultrasound. 1991; 19:221-3.
11. Ekerhovd E, Weijdegård B, Brännström M, Mattsby-Baltzer I, Norström A. Nitric oxide induced cervical ripening in the human: Involvement of cyclic guanosine monophosphate, prostaglandin F(2 alpha), and prostaglandin E(2). Am J Obstet Gynecol. 2002; 186:745-50.
12. Radulovic NV, Ekerhovd E, Abrahamsson G., Norström A. Cervical priming in the first trimester: morphological and biochemical effects of misoprostol and isosorbide mononitrate. Acta Obstet Gynecol Scand. 2009; 88:43-51.
13. Theobald PW, Rath W, Kuhnle H., Kuhn W. Histological and electron-microscopic examinations of collagenous connective tissue of the non-pregnant cervix, the pregnant cervix, and the pregnant prostaglandin-treated cervix. Arch Gynecol. 1982; 231:241-5.
14. Rådestad A., Thyberg J, Christensen NJ Cervical ripening with mifepristone (RU 486) in first trimester abortion. An electron microscope study. Hum Reprod. 1993; 8:1136-42.
15. Chen R, Ning G, Zhao M.L., Fleming MG, Diaz LA, Werb Z, et al Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest. 2001; 108:1151-8.
16. Varayoud J, Ramos JG, Bosquiazzo V.L., Munoz-de-Toro M, Luque EH. Mast cells degranulation affects angiogenesis in the rat uterine cervix during pregnancy. Reproduction. 2004; 127:379-87.
17. Sennström M.K., Brauner A, Lu Y., Granström LM, Malmström AL, Ekman GE Interleukin-8 is a mediator of the final cervical ripening in humans. Eur J Obstet Gynecol Reprod Biol. 1997; 74:89-92.
18. Hattori Y, Nakanishi T, Ozaki Y., Nozawa K, Sato T, Sugiura-Ogasawara M. Uterine cervical inflammatory cytokines, inter-leukin-6 and -8, as predictors of miscarriage in recurrent cases. Am J Reprod Immunol. 2007; 58:350-7.
19. Curry TE Jr., Osteen KG The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev. 2003; 24:428-65.
20. Watari M, Watari H, DiSanto M.E., Chacko S., Shi GP, Strauss JF 3rd. Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. Am J Pathol. 1999; 154:1755-62.
21. Malmström E., Sennström M, Holmberg A., Frielingsdorf H, Eklund E, Malmström L, et al The importance of fibro-blastsin remodelling of the human uterine cervix during pregnancy and parturition. Mol Hum Reprod. 2007; 13:333-41.
22. Sennström M.B., Brauner A, Byström B, Malmström A, Ekman G. Matrix metalloproteinase-8 correlates with the cervical ripening process in humans. Acta Obstet Gynecol Scand. 2003; 82:904-11.
23. Stygar D, Wang H, Vladic Y.S., Ekman G., Eriksson H, Sahlin L. Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. Biol Reprod. 2002; 67:889-94.
24. Aronsson A, Ulfgren AK, Stabi B, Stavreus-Evers A, Gemzell-Danielsson K. The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical ripening during early pregnancy. Contraception. 2005; 72:33-9.
25. Olson MW, Toth M, Gervasi D.C., Sado Y., Ninomiya Y, Fridman R. High affinity binding of latent matrix metalloproteinase-9 to the alpha2(IV) chain of collagen IV. J Biol Chem. 1998; 273:10672-81.
26. Tarlton JF, Vickery CJ, Leaper D.J., Bailey AJ Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9. Br J Dermatol. 1997; 137:506-16.